HIGHMARK APPOINTS DMYTRO P. YEVTUSHENKO, PHD. AS SCIENTIFIC ADVISOR
Highmark Marketing Inc. has appointed Dr. Dmytro P. Yevtushenko, PhD, as scientific adviser.
Dr. Dmytro P. Yevtushenko is an accomplished scientist in the area of plant biology and biotechnology. He holds a PhD in cell biology from the Institute of Cell Biology & Genetic Engineering, and an MSc in plant physiology and biochemistry (with distinction) from Kiev State University, Ukraine. Dr. Yevtushenko’s research has focused on crop improvement and food safety using modern techniques of molecular biology, genetic engineering and plant tissue culture. In addition, he has a comprehensive knowledge and interest in metabolic bioengineering, secondary metabolite pathways, gene regulation and bioinformatics.
In Dr. Yevtushenko’s past position as director of research and development at Provitro Biosciences LLC, a plant biotechnology company in Mount Vernon, Wash., United States, he worked on the development and implementation of innovative research programs in plant cell and tissue culture. He previously worked as a research associate in the Centre for Forest Biology and senior scientist at SynGene Biotek Inc., department of biochemistry and microbiology at the University of Victoria, B.C., Canada.
Dr. Yevtushenko is the author of over 50 publications, including research articles published in peer-reviewed scientific journals. He has presented major research achievements at numerous scientific conferences, symposia and meetings. He holds two patents, which are on methods to increase plant yield.
As scientific adviser, Dr. Yevtushenko has agreed to provide Highmark with industry intelligence and updates, and to work closely with management to develop business strategies that take advantage of current and future market opportunities.
According to Health Canada, a licensed producer of marijuana must have an employee designated as a quality assurance person who is responsible for assuring the quality of dried marijuana. Highmark is not a licensed producer of marijuana, but it announced in a news release dated June 24, 2014, that it had entered into a binding letter of intent with BCBUD Producers Inc. to acquire 100 per cent of the authorized share capital of BCBUD. BCBUD has an option to lease a 27,000-square-foot building in the township of Langley, B.C. The property is zoned M-2, and when the facility is operational, it could be capable of producing up to two million grams (4,409 pounds) of medical marijuana per year, with the additional possibility of expansion adjacent to the site. BCBUD has prepared an application to become a licensed producer. It is not known if and when BCBUD will obtain the requisite licence. The key milestones to obtaining the licence include filing an application, receiving a ready-to-build notice, completion of the upgrades as per the application, approval to produce upon inspection of the facility and finally approval to distribute the product to patients. If Highmark does become a licensed producer of marijuana, Dr. Yevtushenko will assist Highmark with fulfilling its quality assurance requirements under the Marihuana for Medical Purposes Regulations (MMPR) program.
In addition, and more specifically, the scientific adviser has agreed to make his knowledge and expertise available to advising Highmark regarding research and development on marijuana and marijuana strains, as well as advising on research and development methods with the view to improving yield. Any research and development concerning marijuana may be subject to necessary governmental approval.
As consideration for services provided, Highmark will grant Dr. Yevtushenko, in accordance with the company’s stock option plan, an incentive stock option to purchase 50,000 common shares in the capital of Highmark.
Highmark looks forward to working with Dr. Yevtushenko and learning from his expertise to further Highmark’s business in the medical marijuana sector.
July 9, 2014, news release
Highmark would also like to revise the news release dated July 9, 2014, which announced the close of the first tranche of a non-brokered private placement. Finders were inadvertently described as agents. All other content of that news release remains unchanged.
We seek Safe Harbor.
© 2014 Canjex Publishing Ltd. All rights reserved.
- Published in Medical Marijuana
Affinor Growers Completes 45-Acre Land and Facilities Acquisition in Quebec to Produce Strawberries
MONTREAL, CANADA — (Marketwired) — 07/21/14 — Affinor Growers (CSE:AFI)(OTCQB:RSSFF)(FRANKFURT:1AF) (“Affinor” or the “Corporation) has purchased 45 Acres of agriculture property in St-Chrysostome, Quebec, for $340,000.
An offer has been accepted on the 45 acres of prime land south of Montreal and Affinor Growers plans to build a state-of-the-art, strawberry-growing facility in St-Chrysostome, Quebec.
Sebastien Plouffe, president and CEO, comments: “This acquisition is strategically perfect for our distribution plans because it’s located about 30 minutes from Montreal and only few kilometers from the New-York State Border. We’re proud to be able to build the facitliy in the Province of Quebec renowned for it’s agriculture experts and know-how. The Quebec provincial government has incentives for investment into agriculture and job creation, and the Affinor Growers team is excited to explore ways to best collaborate and expand into such a unique culture in Canada. We will be very proactive to begin construction of this facility to satisfy our future clients.”
Update on Affinor Growers:
After completion of due diligence, the Affinor Growers board of directors have decided not to proceed with the LOI signed and announced on June 9, 2014. Fab-All will still continue to build parts for the Vertical Design equipment as Fab-All produces excellent, high quality products.
Affinor Growers will also not complete the land acquistion in Saskatchewan and will instead concentrate it’s effort on building a facility in St-Chrysostome, Quebec and to complete the acquisition of the Vancouver rooftop garden.
About Affinor Growers Inc.
Affinor Growers is a diversified publicly traded company on the Canadian Securities Exchange under the symbol (“AFI”). Affinor is focused on growing high quality crops such as romaine lettuce, spinach, strawberries and high quality medical Marijuana. Affinor is committed to becoming a pre-eminent grower, using exclusive vertical farming techniques.
On Behalf of the Board of Directors AFFINOR GROWERS INC. "Sebastien Plouffe" President & CEO
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release
FORWARD LOOKING INFORMATION
This News Release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This News Release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
Contacts:
Contact Information
Sebastien Plouffe
President & CEO
(514) 947-2272
splouffe@affinorgrowers.com
http://www.affinorgrowers.com/en
Contact Information
Momentum PR Inc
Max Gagne, President
(514) 913-0351
max@momentumpr.com
Contact Information, spokesperson
Vertical Designs Ltd
Nick Brusatore, CEO
(604) 356-0411
nbrusatore@gmail.com
- Published in Medical Marijuana
Advocate Cheryl Shuman Discusses CBD Benefits and Cannabis Technologies on CTV Interview
<div class=”itemVideoEmbedded”><a href=”http://www.cannabisfn.com/quote/?ticker=CANLF”>Cannabis Technologies Inc.</a> (<span id=”qmStockQuote”><span class=”qmjssymbol”>CANLF</span> <span class=”qmjsdata”>0,40</span> <span class=”qmjsdataup”>6,35 {92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce}</span></span>), a leading innovator of technology and science within the cannabis sector, was recently highlighted in a Canadian TV (“CTV”) interview discussing the benefits of medical marijuana. As an ovarian cancer survivor, Ms. Shuman has become a leading advocate for the ongoing legalization of cannabis and research conducted by companies in the space, particularly companies like Cannabis Technologies that are working to reduce the time to commercialize cannabis based therapies.</div>
<p>Cannabis Technologies Inc. is a biopharmaceutical drug discovery and development company focused on cannabinoids that has been dubbed by many as the “Junior GW” in the space. By leveraging its proprietary platform, the company’s management team aims to identify new bioactive compounds within the marijuana plant that interact with specific genes to produce meaningful clinical outcomes.</p>
<p>According to Chief Science Officer Sazzad Hossain, the proprietary platform provides the necessary tools to isolate and identify chemical compounds in marijuana in months rather than years. The company will use the platform to isolate compounds targeting specific diseases and conditions and then outsource the early-stage research and trials to get to Phase I as quickly and inexpensively as possible.</p>
<p>Initially, the company plans to focus on the $12 billion ocular disease market, including the $5.7 billion glaucoma market, where its CTI-085 is preparing to undergo Phase I clinical trials shortly. In addition to this area, management has expressed interest in larger markets like pain and inflammation, as well as orphan diseases classified by the FDA like cancers and metabolic diseases.</p>
<p>Just like <a href=”http://www.cannabisfn.com/quote/?ticker=GWPH”>GW Pharmaceuticals plc</a> (<span id=”qmStockQuote”><span class=”qmjssymbol”>GWPH</span> <span class=”qmjsdata”>88,95</span> <span class=”qmjsdataup”>2,70 {92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce}</span></span>), the company also operates a breeding and cultivation division that’s responsible for creating the medicines in-house. The proprietary phyto-stock produced by the division sets it apart from competitors that rely on third-parties to manufacture their treatments, since the fully-integrated operations both lower costs and increase quality.</p>
<p>Shares of Cannabis Technologies were trading even in early trading on Tuesday, July 22, 2014.</p>
- Published in Medical Marijuana
Lakeland Resources Inc. Acquires Newnham Lake Property, Athabasca Basin
Canada NewsWire
VANCOUVER, July 21, 2014
TSXv: LK FSE: 6LL
VANCOUVER, July 21, 2014 /CNW/ – Lakeland Resources Inc. (TSXv: LK) (FSE: 6LL) (OTCQX: LRESG) (the “Company” or “Lakeland”) is pleased to announce that it has acquired the Newnham Lake Property (the “Property”), within the northeast portion of the Athabasca Basin. Newnham Lake is contiguous to the south of the Company’s Karen Lake Property, and increases the company’s land position in the area by approximately 20,218 ha (49,961 acres). The property is situated along the shallow basement margin where depth to basement is expected to be from zero to around 100 metres.
The Newnham Lake Property and surrounding area was the subject of intense exploration efforts by Saskatchewan Mining and Development Corporation (“SMDC”) for shallow, unconformity hosted uranium deposits from about 1976 to 1984. JNR Resources conducted exploration on and near the Property between 1997 and 2011. The recent work includes a ground electromagnetic (HLEM) survey with targets on the Property not yet drill tested. Other recent work includes airborne VTEM and ZTEM surveys and an airborne full tensor gravity gradiometry survey.
The Property encompasses parts of an approximately 25 km long, folded and faulted, graphitic metapelite trend which was the subject of the historic work. In excess of 140 drill holes targeted this trend prior to 1984, and were focused on mineralization at the unconformity. Limited work was done exploring for deeper basement style mineralization despite extensive alteration, anomalous geochemistry and favorable rock types, with most holes continuing less than 25 metres past the sub-Athabasca unconformity. The exploration in the area of the Newnham Lake Property was largely prior to the understanding of the importance of basement-hosted unconformity-style uranium deposits. The Newnham Lake region was one of the most developed trends in the Athabasca Basin, outside of the prolific Eastern Athabasca Trend and Cluff Lake. The company believes that the historic work indicates a large amount of positive exploration indications and that there are several targets yet to be tested.
To the northeast of the Property, within Lakeland’s Karen Lake Property, historic work shows extensive enrichment within lakes and stream sediments of Uranium, Nickel and other pathfinder elements. Organic-rich overburden samples at Karen Lake are reported to contain in excess of 1{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} uranium.
According to Jon Armes, President and CEO of Lakeland Resources “We are excited about the opportunity to acquire another project such as Newnham Lake with significant historic work that suggests the presence of a large mineralized system, as evidenced by highly anomalous uranium, nickel and other pathfinders in both drill holes and surface samples. We look at this as an excellent opportunity to grow the Company’s stable of high-quality projects.”
Concurrent with the acquisition of the Newnham Lake Property, the company has also agreed to acquire the Hatchet Lake Property (the “Hatchet Property”). It is located east of the Company’s recently acquired Fond du Lac Property, and covers the easterly extension of what is interpreted as the same basement graphitic meta-sedimentary basin. The Hatchet Property has not seen any serious historic exploration campaigns despite its favourable geological setting. The Hatchet Property is located approximately 12 kilometres outside of the Athabasca Basin sandstones, and is considered highly prospective for basement hosted mineralization. It also benefits from nearby infrastructure, as is common to all projects located within the northeastern part of the Athabasca Basin, and which are in reasonable proximity to the Uranium Mining and Milling infrastructure.
Lakeland has the right to earn a 100{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} interest in the Newnham Lake Property by making cash payments totaling $100,000 and issuing 2,500,000 common shares over a 24 month period. The Vendor will retain a 2.5{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} GORR, subject to a 1{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} buyback provision. The Hatchet Lake Property can be acquired by making a cash payment of $13,500 and issuing 500,000 shares. The Vendors will retain a 2.5{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} GORR, subject to a 1{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} buyback provision.
NI 43-101 Disclosure
The technical information above has been prepared in accordance with the Canadian regulatory requirements set out in National Instrument 43-101 and reviewed on behalf of the company by Neil McCallum, P.Geo., of Dahrouge Geological Consulting Ltd., a qualified person.
About Lakeland Resources Inc.
Lakeland Resources Inc. is a pure play uranium exploration company focused on the Athabasca Basin in Saskatchewan, Canada; home to some of the world’s largest and richest high-grade uranium deposits. The Company’s common shares trade on the TSX Venture Exchange under the symbol “LK” and on the Frankfurt Stock Exchange under the symbol “6LL”.
On Behalf of the Board of Directors
LAKELAND RESOURCES INC.
“Jonathan Armes”
Jonathan Armes
President, CEO and Director
Cell: 416.708.0243
Ph: 604.681.1568
TF: 1.877.377.6222
Email: jarmes@lakelandresources.com
Web: http://www.lakelandresources.com
Read more: http://www.digitaljournal.com/pr/2066544#ixzz38CrHk7lf
- Published in Mining
Canadian Stocks Advance for Second Day, Led by Canadian Pacific
Canadian stocks rose a second day, extending a record, as Canadian-Pacific Railway Ltd. reported higher-than-estimated profit and gold producers rallied.
Canadian Pacific, the country’s second-largest railroad, rose 3.9 percent after as revenue at climbed faster than expenses, powered by a rise in grain and coal shipments. RMP Energy Inc. (RMP) jumped 4 percent after boosting its 2014 production outlook. Eldorado Gold Corp. and Agnico Eagle Mines Ltd. increased more than 2.2 percent as gold gained a second day in New York.
The Standard & Poor’s/TSX Composite Index (SPTSX) rose 40.18 points, or 0.3 percent, to 15,266.52 at 10:25 a.m. in Toronto. The benchmark Canadian equity gauge has gained 12 percent this year, the third-best performer among the world’s developed markets.
Canadian Pacific climbed 3.9 percent to C$205.54. Leftovers from a record Canadian wheat crop helped Canadian Pacific post a 32 percent jump in grain revenue in that category. Earnings in the latest period also benefited from a 15 percent increase in coal sales.
Industrial stocks added 1.3 percent as a group as four of 10 industries advanced on trading volume 13 percent below the 30-day average at this time of the day.
Eldorado Gold added 2.3 percent to C$8 and Agnico Eagle advanced 2.2 percent to C$44.05 as the S&P/TSX Gold Index jumped 0.9 percent. Gold for August delivery rose 0.4 percent to $1,304.50 an ounce in New York as the U.S. and European Union imposed sanctions on Russian banks, energy companies and defense firms in the latest attempt to pressure the country to halt interference in Ukraine.
BlackBerry Ltd. (BB) slipped 0.9 percent to C$10.62 for a second day of losses after Apple Inc. and International Business Machines Corp. agreed to a collaboration on July 15 that threatens the smartphone maker’s turnaround strategy.
Jul 17, 2014 10:36 AM ET
To contact the reporter on this story: Eric Lam in Toronto at elam87@bloomberg.net
- Published in Business
Canada Stocks Rise to Record as Commodities Rally on China Data
Canadian stocks rose to a record, after falling to a two-week low yesterday, as the central bank kept interest rates steady and commodities advanced the most in a month on faster-than-forecast growth in China.
Barrick Gold Corp. (ABX) gained 2.9 percent after announcing executive changes less than three months after a breakdown in merger talks with its largest rival. Precision Drilling Corp. jumped 4.5 percent after agreeing to a strategic technology and service agreement with Schlumberger Ltd. BlackBerry Ltd. sank 12 percent after Apple Inc. and International Business Machines Corp. agreed to a partnership to reach more businesses.
The Standard & Poor’s/TSX Composite Index (SPTSX) rose 145.02 points, or 1 percent, to 15,226.34 at 4 p.m. in Toronto, jumping the most since April to top a record set July 9. The benchmark Canadian equity gauge has gained 12 percent this year, the third-best performer among the world’s developed markets.
Bank of Canada policy makers kept their benchmark rate on overnight loans between commercial banks at 1 percent, where it’s been for almost four years, and said faster inflation has been caused by one-time gains in energy and import prices, not changes in economic fundamentals.
Canadian factory sales jumped 1.6 percent in May, to C$51.6 billion ($48 billion), after a revised 0.2 percent decline in April, Statistics Canada said today in Ottawa.
Nine of 10 industries advanced on trading volume in line with the 30-day average. Raw-materials stocks jumped 1.3 percent as a group and the S&P/TSX Energy Index rallied 1.4 percent to pace gains in the benchmark equity gauge.
Commodities Rally
The S&P GSCI Index (SPGSCI), which tracks a basket of commodities prices, increased 0.4 percent, the most since June 19. Economic growth beat estimates in China. Gross domestic product rose 7.5 percent in the second quarter in China, the world’s biggest consumer of energy and raw materials, data showed.
Barrick Gold rose 2.9 percent to C$20.28. Chief Executive Officer Jamie Sokalsky said he will be stepping down two years into the job. Kelvin Dushnisky and Jim Gowans will be appointed co-presidents, the company said in a release.
BlackBerry plunged 12 percent to C$10.72, the most since November, after longtime rivals Apple and IBM agreed to a deal yesterday in which IBM will push iPhones and iPads in exchange for a chance to sell software and services to more companies. A key component of BlackBerry’s turnaround strategy has been to target that same business services market.
To contact the reporter on this story: Eric Lam in Toronto at elam87@bloomberg.net
- Published in Business
Alibaba Said to Plan U.S. IPO After H.K. Talks Break Down
Alibaba Group Holding Ltd. is moving toward an initial public offering in the U.S. after talks for a Hong Kong listing broke down following management’s proposal to keep control in a share sale, according to two people familiar with the matter.
China’s largest e-commerce company is seeking U.S. law firms to help with an IPO and hasn’t hired banks yet, said one of the people, who asked not to be identified because the process is private. Alibaba, which investment banks value at as much as $120 billion, is likely to choose to list its shares on the New York Stock Exchange, another person said.
Alibaba founder Jack Ma and partners want to control the Hangzhou-based company after the listing by effectively creating two groups of shareholders, with one group able to nominate a majority of board members. To protect the interests of ordinary shareholders, Hong Kong’s exchange prohibits IPOs with different classes of shares, a structure that has been used by companies from Facebook Inc. (FB) to Manchester United Plc (MANU) in their U.S. initial offerings.
“Jack Ma really insisted on the partnership structure,” said Billy Leung, an analyst at RHB Research Institute Sdn. in Hong Kong. “If you give it to them then you give it to everyone. Alibaba has been waiting for so long, they just said let’s go to the U.S.”
Photographer: Nelson Ching/Bloomberg
‘Emotional Arguments’
Losing the Alibaba IPO would be a blow to Hong Kong, which hasn’t hosted a first-time share sale of more than $4 billion since October 2010. The exchange is the fourth biggest equity market in the world, with companies trading there worth a combined $3.4 trillion in market value, according to data compiled by Bloomberg.
“We need to look objectively at the issues and not be swayed by emotional arguments or be distracted by specific circumstances of any given company or issue,” Charles Li, CEO of Hong Kong Exchanges & Clearing Ltd., said in a blog post today. He didn’t name Alibaba.
While the Nasdaq Stock Market dominated technology listings in the past, winning everything from Intel Corp. to Facebook, the New York Stock Exchange, or NYSE, has established itself as a challenger in the most recent wave of offerings. Since mid-2011, LinkedIn Corp., Pandora Media Inc. and Yelp Inc. have listed there, and Twitter Inc. is also leaning toward the NYSE, a person with knowledge of the matter said this week.
Alibaba declined to comment in an e-mail today. Lorraine Chan, a spokeswoman for Hong Kong Exchanges, declined to comment, citing a company policy against discussing individual cases. NYSE Euronext (NYX) spokesman Rich Adamonis also declined to comment on Alibaba’s IPO plans as did William Briganti at Nasdaq OMX Group Inc.
Photographer: Nelson Ching/Bloomberg
Partnership Control
Alibaba may appoint underwriters by the end of this year, one of the people familiar said. While a final decision hasn’t been made, the company may use a partnership structure similar to what it proposed in Hong Kong, the person said.
For weeks, Alibaba and the Hong Kong exchange discussed the proposal to let partners control most board nominations. That would let Ma, a former English teacher who owns 7.4 percent of the stock, and his managers run the company without worrying about being pushed out by an activist investor with a different strategy, a person familiar with the matter said last month.
The company had 28 partners as of Sept. 10, Ma said in an e-mail to employees this month. They include co-founder Joseph Tsai and Chief Executive Officer Jonathan Lu.
Investor Rights
Under Alibaba’s partnership proposal, all shareholders would still vote on the proposed directors with partners being able to nominate an alternate if shareholders reject a candidate, the person familiar with Alibaba’s thinking said.
No other investor rights would be changed, the person said. Deals involving company executives, major expenses and compensation would be voted on by all shareholders, according to the person.
“This is not a mere profit sharing mechanism, nor is it a vehicle of power to exert greater control over the company,” Ma said in the Sept. 10 e-mail.
Hong Kong’s bourse doesn’t allow share classes with different voting rights, as exchanges in the U.S. do. Under Hong Kong’s listing rules, new applicants must not include shares whose voting power doesn’t bear a “reasonable relationship” to the equity interest.
Manchester United
The dual-class structure helped Facebook’s Mark Zuckerberg and Google Inc. co-founders Larry Page and Sergey Brin keep control of their companies after they went public. Manchester United, the English soccer club, also considered a share sale in Hong Kong before eventually settling on the U.S., where Class B shares owned by the Glazer family carry 10 votes apiece versus one vote each for the Class A shares sold in the IPO.
“They can go to the U.S. and accept the U.S. environment with more stringent reporting requirements and a class action litigation system and benefit from the dual-class voting structure,” said David Webb, founder of local governance watchdog Webb-site.com and a former director of the exchange.
Ma started Alibaba in his Hangzhou apartment in 1999 with two dozen items for sale, and the company’s expansion mirrors China’s emergence as an economic superpower. The company now has 24,000 employees and generates about 70 percent of package deliveries in China. Customers bought at least 1 trillion yuan ($163 billion) of goods via Alibaba last year.
That success has made Ma, 49, one of China’s richest people with an estimated net worth of $3.7 billion, according to the Bloomberg Billionaires Index.
There is still room for growth. China has 591 million Internet users, greater than the population of any other country except India, and McKinsey & Co. estimates China’s Internet retail market will triple to $395 billion from 2011 to 2015.
Alibaba’s Valuation
In a July 17 report, Evercore Group LLC estimated an Alibaba IPO could value the company at $120 billion, based on a forecast that operating profit could reach $7.1 billion in 2014. Goldman Sachs Group Inc. on July 22 put Alibaba’s value at about $105 billion.
At $120 billion, Alibaba would be the third-biggest Internet company behind Google (GOOG) and Amazon.com Inc. (AMZN) based on market capitalization.
Alibaba could raise about HK$100 billion ($12.9 billion) in an initial sale, Ernst & Young LLP said June 28. That would make it the world’s biggest IPO since Facebook raised $16 billion in May of last year, and Hong Kong’s largest since AIA Group Ltd. (1299)’s $20 billion sale in October 2010, according to data compiled by Bloomberg.
The IPO of Facebook valued the company at $104 billion, and the shares lost as much as half their value in the first few months of trading before starting to recover.
Yahoo, SoftBank
Alibaba is considering a more conservative valuation than Facebook for its IPO, a person with knowledge of the matter said earlier this year.
Alibaba’s profit in the latest quarter tripled from a year earlier to $669 million, Yahoo! Inc. said in July. Facebook earned $217 million in the same period and Tencent posted net income of 4.04 billion yuan.
Japan’s SoftBank Corp. (9984) owns about 37 percent of Alibaba and Yahoo about 24 percent, the companies said separately in July. Hiroe Kotera, a Tokyo-based spokeswoman for SoftBank, declined to comment today about Alibaba’s IPO plan.
After starting as a business-to-business marketplace on Alibaba.com, where companies trade anything from shoelaces to steel, the company has morphed into a more consumer-focused operation. Its most popular platforms include Taobao Marketplace, which links individual buyers and sellers, and Tmall.com, which connects consumers to companies such as Microsoft Corp., Procter & Gamble Co. and Japanese clothing chain Uniqlo.
- Published in Blog
Active Component Of Marijuana Has Anti-cancer Effects, Study Suggests
Guillermo Velasco and colleagues, at Complutense University, Spain, have provided evidence that suggests that cannabinoids such as the main active component of marijuana (THC) have anticancer effects on human brain cancer cells.
In the study, THC was found to induce the death of various human brain cancer cell lines and primary cultured human brain cancer cells by a process known as autophagy.
Consistent with the in vitro data, administration of THC to mice with human tumors decreased tumor growth and induced the tumor cells to undergo autophagy. As analysis of tumors from two patients with recurrent glioblastoma multiforme (a highly aggressive brain tumor) receiving intracranial THC administration showed signs of autophagy, the authors suggest that cannabinoid administration may provide a new approach to targeting human cancers.
Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells
Story Source:
The above story is based on materials provided by Journal of Clinical Investigation. Note: Materials may be edited for content and length.
- Published in Medical Marijuana
Some tips on improving your online presence
Job seekers in today’s increasingly competitive economy are highly encouraged to take the time to create the right online presence. Here are some expert tips:
— Register your domain name in as many variants as you can find and as early as you can — even using likely misspellings. That will give you control over any searches in your name.
— Write a blog on Tumblr and map your domain name on it. When you blog, do it as if you’re at the local pub, not in a sequestered room.
— Register for as many profiles on as many sites as you can so that, as you grow your career, you can dominate as much of the first page as possible to develop your Klout score.
— Use About.me to create landing pages.
— A LinkedIn account is a must, but you can go the extra step and get a LinkedIn vanity name, so your name comes up in your profile’s URL. It’s a way to show attention to detail.
— Go through your previous online posts and delete anything irrelevant, frivolous or controversial.
— Don’t misrepresent yourself.
- Published in Blog
Affinor Growers (C.AFI) likes weed fine, but sees bigger profits in food
Some have big plans but no license. Others have a license but have yet to make good use of it.
Affinor Growers (CSE:C.AFI, Stock Forum) is one of the 800 or so companies hoping to receive eligibility as a Health Canada licensed producer of medical marijuana by the end of 2014 but, unlike most, its existence doesn’t depend on that decision.
In fact, the company sees profits as good – if not better – in other areas… Areas that don’t require a long period waiting for Health Canada to process a license application.
Affinor’s promotional material features a strawberry with a bite taken out of it, with the slogan “Think differently, again,” a play on Apple Computer’s famous ‘think differently’ campaign from years gone by.
And it’s an accurate reflection on how the company is doing business. Though the Apple association may be a little premature, the plan, as laid out by Affinor Chairman and Advisor (and technology supplier, and pitchman) Nick Brusatore, is to create multiple revenue streams so that the organization is ‘sector-proof’ – riding the ups when they happen, and being able to rely on new opportunities as the downs settle in.
In short, while the rest of the sector is waiting to be given permission to grow weed, Affinor is moving forward with a plan to grow strawberries.
Using their fully automated, software-driven, vertical grow technology of Brusatore’s just absorbed company Vertical Designs to produce non-GMO, mechanically pollinated, high yield, high shelf-life, high demand, fruits and vegetables, Affinor hopes to show investors that it isn’t a weedco, but an aggressive, technology-driven agricultural giant in the making.
To be sure, that’s a complicated story for a lot of drive-by investors. People tend to boil the Affinor story down to their being “strawberry growers”, as a casual insult cast from the cheap seats, rather than look at the justification behind the decision.
Just like medical marijuana vertical integration success story Abattis Bioceuticals (more on them later), Affinor’s opportunity takes some patience to understand. It’s hard to boil it down to one phrase.
Perhaps the best way to describe is is it’s not an ‘if you grow it, they will come’, story. It’s a ‘your weed is going to be worthless soon, so we’re going to set up shop in a way that takes advantage of that’ story.
STAGE ONE: THE PATH TO WEED IS PAVED WITH BUREAUCRACY AND PAIN
Affinor’s current thinking goes, simply, if the company can make as much money growing local, organic, high quality foods as they can growing medical marijuana, without needing a license to do so, why wait for Health Canada to get its act together permitting the latter option?
The decision to strawberry it up hasn’t been well received in all quarters, but it has been well received in many – and perhaps the ones that matter most; Affinor’s key investors.
Brusatore laughs the criticisms off.
“We’re a little more on the cautious side,” he told me by phone last week. “Weed is a piece of our business; we grow plants and obviously marijuana is a plant. We will do what we can for shareholders through potential opportunities in the medical marijuana business, as long as it provides itself as a positive in a corporate due diligence manner. We’re doing due diligence in things people don’t know we’re doing due diligence for, and I’ll tell you, 90{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} of what is out there in the weed space is crap.”
Because getting an LP approval together is a long process, Affinor’s Plan B recently became its Plan A.
And the market hasn’t punished the company for that pivot. Quite the opposite, in fact: while many of its competitors are struggling to maintain stock surges from earlier in the year as questions are asked about where mega-grows will be able to sell all their pot, and for a price that’s sustainable, Affinor is up 60{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} since late April.
“I can get $100m a year for high quality strawberries, without the potential downside of the marijuana business, and I can do that deal right now,” says Brusatore. “I can sign those deals today. So we’re not going to wait for Health Canada to dictate when we can make money for our shareholders, we’re going to go forward with the best plan for right now, we’re going to prove out our technology, and we’re going to get into a revenue situation as quickly as possible.”
STAGE TWO: THE DOUBLE DOWN
Long-time readers may recall the Brusatore name from another party in the MMJ space: the aforementioned Abbatis Bioceuticals (CSE:C.ATT, Stock Forum).
In earlier times, vertical farming expert Brusatore was closely aligned with the front running $37m market cap aggregator in the space, but ultimately took his profits and made the shift to Affinor when that group began collecting a who’s who of big brains and showed strong interest in his technology in areas beyond weed.
“I had recently made a small fortune on Abattis stock and was looking for the next opportunity. What I suggested we do at Affinor was to create a strong market cap, good liquidity and pay attention to the stockholders. I wanted smart people thinking about different ways to approach things. They agreed and we started making quiet plans to work together.”
Brusatore moved a significant chunk of his Abattis winnings into Affinor, backing himself and his technology as much as the team he was joining. The Chairmanship came after he had bought a large holding in the business.
“Prior to signing, I bought as much as I could and started hammering the bids. People thought I was out of my mind; I could have bought a shell for nothing, but I wouldn’t have what I have if I did that. There are some incredible people in this company and I wanted to be a part of that.”
STAGE THREE: THE SOFT SELL
Affinor’s tendency to not over-promote was an important attraction too, though it must be said if you put a microphone in front of Nick Brusatore, he’s going to make it work hard.
Dude can talk. As this interview will show.
“When you create 200-baggers in the stock market, it creates a lot of attention across the sector,” he says. “As a company, we’re into marijuana, we have our own facility, we’re waiting for its licence but when people call us on the phone, I’m not telling them ‘it’s coming any day now,’ because I don’t know that it is. I hate that promotional crap. The company should be good enough that you don’t need to make big promises. Just do good business and you’ll attract a following.”
Busatore has seen a lot of big talk in the early stage weed business, but he says he’s determined not to add to it with outrageous promises.
“I won’t BS investors like a lot of other guys out there because we don’t know; nobody does,” he says. “We think we’re getting there, we’ve got a lot of very smart people working on it and we’re putting together an amazing facility, and we can assist in the development of the market based on our partnerships and scale possibilities, but I just don’t trust it when someone says they’re right around the corner from being legal. That’s not what we do.”
The strawberry plan, to Brusatore, makes economic sense, at least in the short term. It gives the company time to perfect its facility, practices, technology and grow model, while earning revenue and not risking product recalls or breaking the law, something few competitors can boast.
“We’re a plant producer and processor. With the vertical grow technology, we can produce on a scale nobody can compete with. Starting with food, specifically strawberries but there’s potential for other high value crops. We have 20 acres for our greenhouse with our own technology, and we can produce $100m in fresh strawberries with $50m in set up costs. 35{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} net. Trade secrets in our tech.”
Brusatore says he appreciates the excitement building behind his company, but believes investors haven’t seen anything yet.
“The meat and potatoes is on the way,” he says. “The building, land assets, revenues, a real business plan by people with experience in the business, this is what the market needs, not LOIs to build vaporizers in the Honduras. Frankly, most of the industry makes me sick. I’m so glad the exchange put out a warning to investors, though we kind of got caught up in it. Sadly, when Bloomberg wrote about that news release we got grouped in with some random pump and dumps, and we might have to sue Bloomberg for that if they don’t issue a retraction.”
Behind the scenes, Affinor is doing a lot more than growing strawberries, including serious work in the medical marijuana business. The plan includes lining up behind other companies with distribution channels and a need for product to supply them, rather than building a patient database from scratch.
“There are lots of people who have potential distribution,” says Brusatore. “We’ve been looking at the path of least resistance, and least cost to shareholders. People who are really lining up the distribution end of the game, we’ll supply them in bulk. We can set them up with packaging, analytics, protocols, automation; we do that for food so it’s second nature for us.”
He adds, “We just want to get a license, make small alignments, follow the rules closely, and do what we’re good at. We don’t want to go too deep into speculative deals; we’ve only issued about 10{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} of agreed stock payments to potential partners. If they don’t get a license, they don’t get the rest of stock. We’re in talks with number of large groups who are currently licensed who want to purchase production, so we might get involved in a streamlined consolidation move.”
PART FOUR: WEED AS WHEAT
Part of the reason Affinor isn’t diving headlong into an all or nothing marijuana grow approach is the increasing belief – one also held by Brusatore – that there’s likely to be a glut of medical marijuana product in in Canada before long, and a real lack of distribution options for some companies, which will put increasing pressure on pricing.
And by ‘pressure on pricing’, he means the bottom’s going to fall out of the market.
This is something I’ve been saying for some time, and it’s a theory picking up steam.
“The price will tank quickly,” says Brusatore. “Guys that need to get a big price for their marijuana to survive will tank as the global market opens up and people continue to grow their own. Legalization will come fairly quickly but when that happens, will it be grown cheaper in Lakeshore, Ontario, or Uruguay or Jamaica or who knows where?”
“I think with the mega-grows, what they need to be concerned with is Argentina and Brazil. When you can grow it there, nobody will grow here. Bedrocan can produce for $100 per lb, but to me it looks like the price will be driven down by the global market. The licensing terms from Health Canada are so short – I talk to license-holders and they want $10m-$20m for a license, but who will invest that sort of money for a one year term?”
Brusatore thinks we’ll be looking at a base weed price of $75-100 per lb before long. “Similar to tobacco,” he says.
He also sees a lot of issues with some of his competitors, including the first public license-holder to market, Tweed (TSX:V.TWD, Stock Forum).
“I look forward to looking at their quarterlies,” he says. “Their burn is high, cost to produce is high, and then you’ve got to sell everything through legitimate channels. There are some difficulties, that’s for sure. This is why I think there’s more money in strawberries right now.”
Brusatore says he was so concerned with the overall Canadian weed sector that he had planned to produce a video warning investors about what he considers to be some of the shadier plays on the market (no names for the moment), but the exchange beat him to the punch, releasing their own warning.
“People need to look at just the basic set of numbers; the cash in hand, the burn rate, the market cap. If they don’t line up in decent sequence, I don’t care what the stock is doing, it’s a bad deal.”
Which is part of the reason why Brusatore sees value in the food space.
“The big funds and major players are more interested in food right now. They have their eye on weed but it’s a 9:1 ratio for food vs marijuana because nobody has stuck their head above the crowd and demonstrated solid revenues and legitimacy yet.”
Which isn’t to say Affinor isn’t growing a little test crop on the back forty.
“As far as growing marijuana, we’re pretty well versed. We’re growing right now. Our plants are impeccable. We know what we’re doing. I was in Rolling Stone in 2000 in an article about marijuana, we’ve been all over CNN about growing marijuana. It’s so easy to grow I don’t even bother growing it. Now, good strawberries? That’s a tough one.”
Brusatore says the berry plan is for the product to be greenhouse-grown, 100{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} organic, and produced in a 13-level stack that makes extremely tight use of the facility footprint. The crop will be mechanically pollinated, and the process has been designed and patented by his company, Vertical Designs.
“Canada imported $400m of berries last year,” he says. “If I only supply Canada, $400m is not a bad market.”
“There are lots of exotic type things we can’t grow in Canada unless it’s in a greenhouse. Our country is a wheat, canola, corn kind of agricultural landscape. The bio-makeup of the country is fit for those. If you’re growing indoors, economics, power, the cost to create environments, alternative energy, geothermal, solar, wind – all these things will come into play, so you want to be growing something with strong margins but that you can also turnaround quickly. Our system adds vertical growing to the mix to enhance profitability. Once operations up here in Canada are working, we will license all over the world very quickly. People are already coming at us, we’re closing mega-deals all over world, the opportunities are clearly there. But we’ll build the cookie cutter program first, have someone cut us a cheque, sign the deal, and here we go.”
STAGE FIVE: WORLD DOMINATION
For a guy who doesn’t want to over-promote, clearly Brusatore is a bit of a Chatty Cathy. He’s a fan of what he’s got, what’s he’s done, and believes heavily in where he’s going. And he’s the type of guy who is always moving forward, perhaps to a fault.
At a cocktail party Thursday at Vancouver’s Hotel Georgia, Brusatore announced the company has done a deal with Lululemon founder Chip Wilson to take over the failed Local Gardens rooftop urban farming operation built on top of a parkade on Vancouver’s Richards Street. The 5700 sq. ft. space was expected to turn in 150,000 lbs of produce per year for local restaurants, with 20 times usual yield and under 8{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} of traditional water consumption, but didn’t have the capital to continue operations through early growing pains (no pun intended, but I’ll take credit for it) and filed for bankruptcy just 18 months after it opened.
To Brusatore’s credit, he’s getting a facility for pennies on the dollar. But he’s also sold his own Vertical Designs firm to Affinor this week, and acquired a metals fabricator to build parts for his operation in Washington State-based Fab-All, and he maintains a connection with the surging cannabinoid biotech stock Cannabis Technologies (CSE:C.CAN, Stock Forum), and you get the impression if he spotted a ten by ten East Van backyard greenhouse full of dreamcatchers and cracked flowerpots, he’d at least knock on the door and see what they wanted for it.
Those acquisitions haven’t been warmly accepted by the market in the last week. Concerns over focus, dilution, and how the pieces will all fit into one plan are fair. Brusatore says the pieces are all part of the same puzzle. He’s locking down every aspect of the business that he can.
“We want to own revenue streams all over,” he says. “When we bought Vertical Designs, we bought a company with contracts with some of the biggest food producers to set up facilities. When we bought Fab-All, they supply all of our parts for the grow systems. Now that’s locked down. The rooftop is a value deal for a substantial grow facility right in the middle of downtown Vancouver.”
Company CEO Sebastien Plouffe agrees, stating in a news release; “This acquisition will position Affinor Growers as one of the world’s most profitable vertical farming companies. On closing of the [Vertical Designs] transaction and after construction of the first production facility, Affinor Growers will gain additional income streams from equipment sales, royalties on licence agreements, consulting and profits from selling crops.”
“I understand farming isn’t sexy,” Brusatore says. “Even automated, multi-level farming. But hey, y’all gotta eat, right? Weed is a luxury. Food is a necessity. Look around the world – there’s water conservation issues, biological issues in fields, food security issues, bee pollinators are dying, so we’re focused on food right now because it’s a problematic market, and Affinor can become a problematic crop problem solver for the world, in automated form.“
Affinor is moving on strawberries right now, but sees the potential for even bigger margins in other areas, once the science and growing model are proven out.
“We’re looking at things like grapes, asparagus, olives – grapes take eight years to bear fruit. Olives can be 80 to 100 years. But we can manipulate stage one pathways to get fruit earlier in a controlled space. These are issues people aren’t even talking about because people get confused on focus. We’re going to see news releases, shovels in the ground, land purchased, greenhouses built quickly, science advanced. We’re not being crazy, we just want to move to a place where it’s ‘here’s the numbers, and here’s the big purchase order.’”
Brusatore says Affinor is in due diligence currently with some very large groups with a view to rapidly expanding once the model is proven. “Mutual funds, large groups – trust me, they’re not looking at marijuana. They like us because we’re into the food. Or, to put it another way – we can grow marijuana when the time is right, but marijuana growers can’t grow strawberries.”
One potential snag in the plan came with Abattis, who owned the license to use some of Brusatore’s technology in marijuana production. He doesn’t see that as a problem.
“I just developed new technology,” he laughs.
STAGE SIX: GETTING PAST THE HYPE TROUGH
To be clear, Affinor does not present a slam dunk in the sector, at least not yet. Just as the Health Canada licensing situation comes with no guarantees, so too does the agriculture sector. A lot of companies in the food space chase whatever crop is hot right now, such as blueberries, which in just a few years became so plentiful there are silos full of 3-year-old frozen product across the northern US.
But Brusatore says that’s part of what motivates him to develop a company that is able to pivot and isn’t dependent on one stream of income, or one crop, or one facility.
“I think what we’ve done is create a real company with real value for shareholders. We’re not betting it all on the marijuana game, and that just differentiates us from the rest and hedges our bets in this arena. We consider ourselves the safe play, the slow and steady, bricks and mortar, stay focused, not get spread out doing unnecessary acquisitions play.”
“I have a very realistic approach about things,” he says. “It’s great if shareholders are believing in your story, but at the end of the day, you better make damn sure you’re making money, not bleeding and diluting to get paycheques. We’ve decided we don’t want to be raising money for wages, we want to build an enduring business entity that produces revenues that more than pay our salaries. There are no bonuses until we’re making money. We’ve chopped salaries to get there sooner.
Brusatore agrees with the increasing stance in the market that there should be no ‘marijuana sector’ – rather, that there are a whole load of sectors that can use cannabis-related products in existing businesses.
“We are a tech company, really. We are an agriculture company. Not a marijuana company. Marijuana is a plant; it’s just a plant. Great, we’re involved in the hype of it all, but it’s not the biggest piece of the puzzle to us. There’s lots of hype and if it breaks out, we’re right there. But right now, people are fighting to get our investors on our bulletin boards to look at other stocks, which is a compliment to us. They see our investors as the ones to come get. We’re being watched by regulators due to the splash we made coming in, they watch us all day long, but they won’t find anything we do that is underhanded so we welcome the attention.”
On the financial side, Brusatore likes the lay of the land right now for his company.
“We’ve got about $3m in the bank, we have low debt, warrant exercising should bring us about $3m-$4m. We should end up with $5m-$6m cash. I just sent in $580k to exercise warrants. We’ve had offerings from other groups to invest, but we don’t need to do a financing. We can do it but not for equity; we could use a bank if we needed for cash. We’re not looking at more dilution. We could borrow another $2m if we needed it. We don’t have to go far to look for financing.”
Brusatore believes recreational marijuana is coming to Canada – especially should Justin Trudeau’s Liberal Party take power at the next federal election. But when/if that happens, he doesn’t expect to see the streets paved with gold.
“It’ll be $20 per pack with $18 taxes per pack. My family used to own liquor stores during prohibition in the 30s, and we’ve already seen this process, we know what’s on the way. Will it be a boutique business or will it be strangled by the big boys? There are lots of places cheaper than Canada and the US to produce medical marijuana. I mean, try to get a tobacco license these days; you can’t do it. There’s no money in it.”
Brusatore’s separation from Abattis is something many insiders have wondered about. He says it wasn’t anything scandalous, just a variation in preferred direction. That should come as no surprise; Brusatore doesn’t call shotgun, he likes to be at the wheel.
“I’ll be honest, it’s wasn’t so much about any issues with Abattis as much as my need to be in control,” he laughs. “It’s a great company and they’re going to do great things, but if something’s not going in exactly my direction, it drives me up the wall. If I do it, I’ll do it my way.”
Brusatore takes great pain to note that the Abattis crowd are “Great guys, good friends, I’m looking forward to their labs getting going, and they’ll have the greatest analytics program in the US. If we end up being in the MMJ space, I’m more than willing to utilise their labs and be a customer. If everyone’s building something that pertains to industry needs, those are the people we want to be aligned with.”
For all his grand plans, the theme that keeps coming up in talking to Brusatore is one I’ve been pounding the podium on for some time; legitimacy. The need to establish real businesses that push past the hype and do things better than the way they’re done right now. The need to return on the investment made and grow in a sustainable way in industries with exponential upside potential.
Brusatore loves hemp. He loves the science. The loves the promise of cannabinoids and medicines that will be derived from them. And he sees the big price surges that have happened in the sector to date as destined for a turnaround before the real businesses in the space start building a long term growth curve.
“What people are forgetting is all these companies with bigger market caps than ours, they’re looking for ways to get past that first surge and taking note as to what we are doing. The daytraders are getting weeded out and larger players are stepping in when they see real businesses emerging. The sector volume is lower today than earlier in the year, but stocks are not dropping. Now people are waiting for the real deal to stand up and start trading. Get it on the rails, become solid, get to the TSX and bigger boards, with revenues and dividends.”
Brusatore’s not in the game, he says, to get rich. Abattis took care of that. Now it’s about empire building.
“I’m really looking forward to getting off the junior boards and becoming a global company. The medical marijuana market is North America right now, but food is global. In the food business, we have offers to build facilities in England, Ireland, the UAE, and Caribbean. License fees on the technology are going to be significant. Consulting feeds will be ongoing. Parts sales will keep money coming in.”
Don’t believe him? Call him up and tell him so.
“I deliberately put my personal cell number on every press release,” says Brusatore. “I take calls from shareholders, if they need to talk, they can call me and hear it straight from my mouth. They don’t feel like they’re being bullshitted by an IR guy. I need control, and that means a lot more work but it’s critical to our team. My reputation has been 15 years in the making and, with what’s happening here, I believe my whole career is on the line every day.”
And the expansion plans? They’re not done yet.
“We’re looking at a pharma facility that’s built. Looking at expanding into drug production maybe. We’re being a little more reserved with that because it’s a big player. Lots of DD with some big boys. We’re doing our best to be transparent and easy to digest, not tie investors up with lots of business models, but if we find something that we think will add to our current model, we’re going to give it a real good look.”
Brusatore has done a lot of explaining over the last few months, as investors haven’t always been into the food over weed plan. But he’s happy with what he’s hearing from people who own Affinor stock.
“I have no investor issues. People understand what we’re doing when they hear me speak, they’re getting it, they know it makes sense. Emails and texts come in all day saying keep it up. Our support is good, and people know I’ve got skin in the game. $2.5m in cash, and my reputation. We’re gonna get it done. With this team behind me, we can’t fail.”
So Nick, about that whole ‘not over-promoting’ thing..
“Solving world hunger and curing cancer; not a bad way to close out a career, eh?” he laughs.
Perchance to dream, Nick. Perchance to dream.
–Chris Parry
Read more at http://www.stockhouse.com/news/newswire/2014/07/15/affinor-growers-c-afi-likes-weed-fine-but-sees-bigger-profits-food#avfgWOch4pxDQTeG.99
- Published in Medical Marijuana